AED 2022, Day 3, Session 2: India’s Contribution to Reducing Global Vaccine Inequity

COVID Vaccine Reformulated to Target Variants #shortsПодробнее

AED 2022, Day 2, Session 3: New Directions for World Trade & The WTO – Challenges and OpportunitiesПодробнее

India's covid vaccination drive sets two billion dose-record in just 18 months | WIONПодробнее

India launches its first nasal vaccine 'iNCOVACC' against COVID-19 | WION ShortsПодробнее

Here's An Update On The Global Vaccination Race Against COVID-19 | India TodayПодробнее

Oxford Vaccine In India: Serum Institute Gets Nod For Phase 2, 3 Clinical Trials; Here Are ProtocolsПодробнее

Asia Economic Dialogue (AED) 2022, Session 2: Economic Policy for Sustained Post-Pandemic GrowthПодробнее

Asia Economic Dialogue (AED) 2022, Session 3: Can Asian Industry Lead in the Post-Pandemic World?Подробнее

Biological- E Covid Vaccine Set To Become 3rd 'Made In India' VaccineПодробнее

India starts vaccinating its 1.3 billion people against COVID | DW NewsПодробнее

COVID in India: Supply shortage hampers vaccine rollout | COVID-19 SpecialПодробнее

India aims to vaccinate 300 million against Covid by July | DW NewsПодробнее

WHO Urges Two-Month Freeze on Booster Shots to Cut Vaccine InequityПодробнее

Coronavirus Latest Update: Global Vaccination Race Against Covid-19 | India TodayПодробнее

Oxford Vaccine Human Trials: Serum Institute Gets Nod For Phase 2, 3 Trials Of Covid VaccineПодробнее

Covaxin phase-3 trial will begin as second trial has successful results | India | Corona VaccineПодробнее

COVID-19 Vaccine: Serum Institute Gets Nod For Phase 2, 3 Clinical Trials Of Oxford Covid VaccineПодробнее

Biological E Completes Phase-2 Covid Vaccine Trial, Gets SEC Nod For Phase-3 | Breaking NewsПодробнее

Bharat Biotech releases Covaxin's price ahead of India's phase 3 of vaccination | COVID-19 VaccineПодробнее